A Review, in support of SDGs 3 and 17, summarising the efforts of a target product profile working group formed after the Sunnylands Summit: The Path Toward Ending HIV, in Feb 7–9, 2019, to develop target product profiles for HIV curative interventions.
Elsevier,

Food, Medical, and Environmental Applications of Polysaccharides, 2021, Pages 381-400

This chapter advances SDGs 3 and 11 by covering the latest advances in biosensors, which play an innovative role in biomedical applications and improving healthcare. Additionally, the focus is on biosensors derived from natural polysaccharides, i.e. sustainable, bio-based materials.
This book chapter advances SDG 3 by explaining how sex steroids (hormones), through their interactions with the sex steroid receptors present in the heart and vasculature, and their metabolic effects, play a vital role in cardiovascular (CV) health.
This book chapter advances SDG 3 by explaining how peripartum cardiomyopathy (PPCM) is a significant cause of pregnancy-associated morbidity and mortality.
This book chapter advances SDG 3 by explaining how there are many strategies that have been implemented to increase the transplant donor pool, yet the gap between the demand and the offer remains too wide and, as a consequence, the number of patients dying on the waiting list keeps rising.
This book chapter advances SDG 3 by explaining how many scientists share the conviction that human stem cell technology and greater understanding of stem cell biology will in the coming decades fulfill much of its promise and revolutionise medicine as we know it today, improving patient care without past precedent.
This book chapter advances SDG 3 by explaining how the role of biotechnology as a forerunner in the pathway of revolution of human lives has been promising in the recent past. The achievements of biotechnology in the bio-medical front encompass various products like novel vaccines, diagnostic devices, and novel therapeutic strategies.
Elsevier,

Gemma C. Cotton, Natalie R. Lagesse, Liam S. Parke, Carla J. Meledandri, 3.04 - Antibacterial Nanoparticles, Editor(s): David L. Andrews, Robert H. Lipson, Thomas Nann, Comprehensive Nanoscience and Nanotechnology (Second Edition), Academic Press, 2019, Pages 65-82

This chapter advances SDGs 3 and 6 by showing how increasing bacterial resistance to commonly used antibiotics is a pressing threat to the human population on a global scale. As the development of new combative drugs is complex, expensive, time consuming and risky, there has been a strong focus in recent years to develop alternative strategies for the treatment of bacterial infections, and nanoscale materials have emerged a strong contender for this purpose.
Elsevier, American Journal of Preventive Medicine, Volume 60, January 2021
Introduction: Although vaccination coverage is high in Kenya relative to other African nations, undervaccinated children remain, making it important to identify characteristics of these children and t
Elsevier, Journal of the American Medical Directors Association, Volume , 2021
Objective: Health disparities are pervasive in nursing homes (NHs), but disparities in NH end-of-life (EOL) care (ie, hospital transfers, place of death, hospice use, palliative care, advance care pla

Pages